MedTech Dive January 30, 2024
Medtronic, Boston Scientific and J&J are among the medtech companies advancing treatments in cardiac care for when medicines are not enough.
Medical technology companies in 2024 are launching devices that address two especially vexing challenges affecting millions of heart patients: high blood pressure and atrial fibrillation, a form of irregular heartbeat. Company executives anticipate multibillion-dollar markets for these treatments, and they have key developments lined up for this year.
Medtronic, Boston Scientific, Johnson & Johnson and Abbott are tackling AFib with a new technique that uses pulsed field energy to ablate heart tissue and new approaches to prevent blood clots from escaping the heart’s left atrial appendage.
Medtronic is pushing ahead with the introduction of a novel procedure called renal...
Today's Sponsors
Today's Sponsor